The genetic correction of each individual man’s PSA level did not improve discrimination between men at high and low risk of progression compared to the traditional single PSA threshold applied to all men when identifying prostate cancer at high risk of progression in men with a PSA level between 3-10ng/mL. Here, KLK3 is linked to prostate cancer.